Current Clinical Trials

Department: Oncology
Diagnosis: Oncology - General
Principal Investigator: Lowry MD, Philip
Sub-Investigator(s):
  • Morelli PA-C, Catherine
  • O'Neil PA-C, Kelby
  • Perry-Keaty, Cynthia
  • Schecter FNP, Jennifer
Sponsor: ECOG-ACRIN
Details (Identifier #): NCT02201992
Title: E4512, A Randomized Phase III Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Observation for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
Department: Oncology
Diagnosis: Breast
Principal Investigator: Lowry MD, Philip
Sub-Investigator(s):
  • Morelli PA-C, Catherine
  • O'Neil PA-C, Kelby
  • Perry-Keaty, Cynthia
  • Schecter FNP, Jennifer
Sponsor: ECOG-ACRIN
Details (Identifier #): NCT02445391
Title: EA1131, A Randomized Phase III Post-Operative Trial of Platinum Based Chemotherapy vs. Capecitabine in Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Department: Oncology
Diagnosis: Lung- Non-Small Cell
Principal Investigator: Lowry MD, Philip
Sub-Investigator(s):
  • Morelli PA-C, Catherine
  • Perry-Keaty, Cynthia
Sponsor: ECOG-ACRIN
Details (Identifier #): NCT02595944
Title: EA5142, Adjuvant Nivolumab in Resected Lung Cancers (ANVIL)-A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers
Department: Oncology
Diagnosis: Lung- Small Cell
Principal Investigator: Lowry MD, Philip
Sub-Investigator(s):
  • Morelli PA-C, Catherine
  • O'Neil PA-C, Kelby
  • Perry-Keaty, Cynthia
  • Schecter FNP, Jennifer
Sponsor: ECOG-ACRIN
Details (Identifier #):
Title: Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Lung Cancer
Department: Oncology
Diagnosis: Melanoma
Principal Investigator: Lowry MD, Philip
Sub-Investigator(s):
  • Morelli PA-C, Catherine
  • O'Neil PA-C, Kelby
  • Perry-Keaty, Cynthia
  • Schecter FNP, Jennifer
Sponsor: ECOG-ACRIN
Details (Identifier #): NCT02224781
Title: EA6134, A Randomized Phase III trial of Dabrafenib + Trametinib followed by Ipilimumab + Nivolumab at Progression vs. Ipilimumab + Nivolumab followed by Dabrafenib + Trametinib at Progression in Patients With Advanced BRAFV600 Mutant Melanoma
Department: Oncology
Diagnosis: Breast
Principal Investigator: Lowry MD, Philip
Sub-Investigator(s):
  • Morelli PA-C, Catherine
  • O'Neil PA-C, Kelby
  • Perry-Keaty, Cynthia
  • Schecter FNP, Jennifer
Sponsor: ALLIANCE
Details (Identifier #): NCT02750826
Title: Alliance A011401, Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
Department: Oncology
Diagnosis: Genito-urinary - Prostate
Principal Investigator: Lowry MD, Philip
Sub-Investigator(s):
  • Morelli PA-C, Catherine
  • Perry-Keaty, Cynthia
Sponsor: ECOG-ACRIN
Details (Identifier #): NCT03419234
Title: Cabazitaxel With Abiraterone Versus Abiraterone Alone Randomized Trial for Extensive Disease Following Docetaxel: The CHAARTED2 Trial
Department: Oncology
Diagnosis: Breast
Principal Investigator: Lowry MD, Philip
Sub-Investigator(s):
  • Morelli PA-C, Catherine
  • O'Neil PA-C, Kelby
  • Perry-Keaty, Cynthia
  • Schecter FNP, Jennifer
Sponsor: ALLIANCE
Details (Identifier #): NCT02927249
Title: A011502, A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for Node Positive HER2 Negative Breast Cancer: The ABC Trial
Department: Oncology
Diagnosis: Oncology - General
Principal Investigator: Lowry MD, Philip
Sub-Investigator(s):
  • Morelli PA-C, Catherine
  • O'Neil PA-C, Kelby
  • Perry-Keaty, Cynthia
  • Schecter FNP, Jennifer
Sponsor: NCI
Details (Identifier #): NCT02465060
Title: Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Department: Oncology
Diagnosis: Lung- Non-Small Cell
Principal Investigator: Lowry MD, Philip
Sub-Investigator(s):
  • Morelli PA-C, Catherine
  • O'Neil PA-C, Kelby
  • Perry-Keaty, Cynthia
  • Schecter FNP, Jennifer
Sponsor: ALLIANCE
Details (Identifier #): NCT02193282
Title: A081105, Randomized Study of Erlotinib or Observation in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)
Department: Oncology
Diagnosis: Breast- Metastatic
Principal Investigator: Lowry MD, Philip
Sub-Investigator(s):
  • Morelli PA-C, Catherine
  • O'Neil PA-C, Kelby
  • Perry-Keaty, Cynthia
  • Schecter FNP, Jennifer
Sponsor: MacroGenics
Details (Identifier #): NCT02492711
Title: MacroGenics SOPHIA, CP-MGAH22-04, A Phase 3, Randomized Study of Margetuximab Plus Chemotherapy vs. Trastuzumab Plus Chemotherapy in the Treatment of Patients with HER2+ Metastatic Breast Cancer Who Have Received Prior Anti-HER2 Therapies and Require Systemic Treatment
Department: Oncology
Diagnosis: Lung- Miscellaneous
Principal Investigator: Lowry MD, Philip
Sub-Investigator(s):
  • Morelli PA-C, Catherine
  • O'Neil PA-C, Kelby
  • Perry-Keaty, Cynthia
  • Schecter FNP, Jennifer
Sponsor: ALLIANCE
Details (Identifier #): NCT02194738
Title: Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Department: Oncology
Diagnosis: Oncology - General
Principal Investigator: Lowry MD, Philip
Sub-Investigator(s):
  • Morelli PA-C, Catherine
  • O'Neil PA-C, Kelby
  • Perry-Keaty, Cynthia
  • Schecter FNP, Jennifer
Sponsor: Mirati
Details (Identifier #): NCT02219711
Title: Mirati 516-001: A Phase 1/1b Study of MGCD516 in Patients With Advanced Solid Tumor Malignancies
Department: Oncology
Diagnosis: Breast
Principal Investigator: Gergel MD, Thomas
Sub-Investigator(s):
  • Yumen, Omar
Sponsor: ALLIANCE
Details (Identifier #): NCT03414970
Title: A221505, Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Department: Oncology
Diagnosis: Breast- Adjuvant
Principal Investigator: Lowry MD, Philip
Sub-Investigator(s):
  • Morelli PA-C, Catherine
  • O'Neil PA-C, Kelby
  • Perry-Keaty, Cynthia
  • Schecter FNP, Jennifer
Sponsor: NRG
Details (Identifier #): NCT02488967
Title: NRG-BR003: Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
Department: Oncology
Diagnosis: Hematology- Lymphoma
Principal Investigator: Lowry MD, Philip
Sub-Investigator(s):
  • Morelli PA-C, Catherine
  • O'Neil PA-C, Kelby
  • Perry-Keaty, Cynthia
  • Schecter FNP, Jennifer
  • Srivatana MD, Panit
Sponsor: Roche
Details (Identifier #): NCT02624986
Title: BH29812, A phase Ib/II study evaluating the safety and efficacy of obinutuzumab in combination with idasanutlin in patients with relapsed or refractory follicular lymphoma and obinutuzumab or rituximab in combination with idasanutlin in patients with relapsed or refractory diffuse large B-cell lymphoma
Department: Oncology
Diagnosis: Genito-urinary - Prostate
Principal Investigator: Gergel MD, Thomas
Sub-Investigator(s):
  • Yumen, Omar
Sponsor: NCI
Details (Identifier #): NCT03274687
Title: NRG-GU003, Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer
Department: Oncology
Diagnosis: Hematology- Lymphoma
Principal Investigator: Lowry MD, Philip
Sub-Investigator(s):
  • Morelli PA-C, Catherine
  • O'Neil PA-C, Kelby
  • Perry-Keaty, Cynthia
  • Schecter FNP, Jennifer
  • Srivatana MD, Panit
Sponsor: Roche
Details (Identifier #): NCT03135262
Title: BH39147, A Phase Ib/II Study Evaluating the Safety and Efficacy of Obinutuzumab in Combination with Idasanutlin and Venetoclax in Patients with Relapsed or Refractory Follicular Lymphoma and Obinutuzumab or Rituximab in Combination with Idasanutlin and Venetoclax in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Department: Oncology
Diagnosis: Head and Neck
Principal Investigator: Lowry MD, Philip
Sub-Investigator(s):
  • Gergel MD, Thomas
  • Morelli PA-C, Catherine
  • Perry-Keaty, Cynthia
  • Schecter FNP, Jennifer
  • Yumen, Omar
Sponsor: NRG
Details (Identifier #): NCT03258554
Title: Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Stage III-IVB Head and Neck Cancer Who Cannot Take Cisplatin
Department: Oncology
Diagnosis: Gastrointestinal - Liver
Principal Investigator: Banerjee MD, Sima
Sub-Investigator(s):
Sponsor: Internal
Details (Identifier #): none
Title: A Humanitarian Device Exemption Use Protocol of TheraSphere For Treatment of Unresectable Primary or Secondary Liver Neoplasia
Department: Oncology
Diagnosis: Lung- Miscellaneous
Principal Investigator: Lowry MD, Philip
Sub-Investigator(s):
  • Morelli PA-C, Catherine
  • O'Neil PA-C, Kelby
  • Perry-Keaty, Cynthia
  • Schecter FNP, Jennifer
Sponsor: SWOG
Details (Identifier #): NCT02154490
Title: Lung-MAP: A Biomarker-Driven Master Protocol for Previously Treated Squamous Cell Lung Cancer
Department: Oncology
Diagnosis: Lung- Non-Small Cell
Principal Investigator: Lowry MD, Philip
Sub-Investigator(s):
  • Morelli PA-C, Catherine
  • O'Neil PA-C, Kelby
  • Perry-Keaty, Cynthia
  • Schecter FNP, Jennifer
Sponsor: BMS
Details (Identifier #): NCT02869789
Title: BMS CA209-817, A Phase IIIb/IV Safety and Efficacy Trial of Flat Dose Nivolumab in Combination with Ipilimumab in Participants with Non-Small Cell Lung Cancer
Department: Oncology
Diagnosis: Breast- Metastatic
Principal Investigator: Lowry MD, Philip
Sub-Investigator(s):
  • Morelli PA-C, Catherine
  • O'Neil PA-C, Kelby
  • Perry-Keaty, Cynthia
  • Schecter FNP, Jennifer
Sponsor: SWOG
Details (Identifier #): NCT02595905
Title: S1416, Phase II Randomized Placebo-Controlled Trial of Cisplatin With or Without ABT-888 (Veliparib) in Metastatic Triple-Negative Breast Cancer and/or BRCA Mutation-Associated Breast Cancer
Department: Oncology
Diagnosis: Lung- Non-Small Cell
Principal Investigator: Lowry MD, Philip
Sub-Investigator(s):
  • Morelli PA-C, Catherine
  • O'Neil PA-C, Kelby
  • Perry-Keaty, Cynthia
  • Schecter FNP, Jennifer
Sponsor: BMS
Details (Identifier #): NCT03090737
Title: "An Open-label, Single-arm Phase II Safety Study of Nivolumab in Participants with Advanced or Metastatic Non-small Cell Lung Cancer Who Have Progressed During or After Receiving at Least Once Prior Systemic Regimen": CA209-907-022
Department: Oncology
Diagnosis: Breast- Metastatic
Principal Investigator: Lowry MD, Philip
Sub-Investigator(s):
  • Morelli PA-C, Catherine
  • O'Neil PA-C, Kelby
  • Perry-Keaty, Cynthia
  • Schecter FNP, Jennifer
Sponsor: SWOG
Details (Identifier #): NCT03418961
Title: S1501, Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Department: Oncology
Diagnosis: Breast
Principal Investigator: Lowry MD, Philip
Sub-Investigator(s):
  • Morelli PA-C, Catherine
  • O'Neil PA-C, Kelby
  • Perry-Keaty, Cynthia
  • Schecter FNP, Jennifer
Sponsor: ECOG-ACRIN
Details (Identifier #): NCT02115282
Title: E2112, A Randomized Phase III Trial of Endocrine Therapy Plus Entinostat/Placebo in Patients With Hormone Receptor-Positive Advanced Breast Cancer